Earum Pharmaceuticals Ltd.
| BSE: 542724 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE060601015 |
| BSE 00:00 | 26 Feb | Earum Pharmaceuticals Ltd |
| NSE 05:30 | 01 Jan | Earum Pharmaceuticals Ltd |
| OPEN | 75.05 |
| PREVIOUS CLOSE | 75.05 |
| VOLUME | 1500 |
| 52-Week high | 87.50 |
| 52-Week low | 48.50 |
| P/E | 25.53 |
| Mkt Cap.(Rs cr) | 46 |
| Buy Price | 95.00 |
| Buy Qty | 1500.00 |
| Sell Price | 75.05 |
| Sell Qty | 1500.00 |
Earum Pharmaceuticals Ltd. (EARUMPHARMACEU) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 640.30 | -0.89 | 653.70 | 434.25 | 153627.17 |
| Divi's Lab. | 3805.15 | -0.49 | 3913.00 | 2094.60 | 101007.71 |
| Dr Reddy's Labs | 4970.55 | 1.58 | 5514.65 | 3613.45 | 82660.25 |
| Cipla | 946.60 | 0.84 | 954.20 | 565.90 | 76338.55 |
| Aurobindo Pharma | 965.50 | 1.31 | 1023.10 | 510.45 | 56568.65 |
| Cadila Health. | 527.30 | 0.06 | 536.60 | 318.10 | 53979.70 |
| Biocon | 406.50 | -1.53 | 487.70 | 320.90 | 48780.00 |
| Lupin | 1061.45 | 0.53 | 1121.85 | 787.60 | 48157.99 |
| Apollo Hospitals | 3155.55 | 3.12 | 3283.90 | 1253.25 | 45370.50 |
| Gland Pharma | 2764.25 | 5.14 | 2806.30 | 1701.00 | 45223.13 |
| Torrent Pharma. | 2595.40 | -0.91 | 3040.00 | 2227.20 | 43919.36 |
| Piramal Enterp. | 1662.95 | -3.29 | 2008.20 | 805.60 | 37507.84 |
| Alkem Lab | 2746.00 | -1.59 | 3150.00 | 2223.55 | 32828.43 |
| Abbott India | 14702.45 | -1.74 | 18569.00 | 13970.10 | 31242.71 |
| Ipca Labs. | 2173.10 | 1.40 | 2455.55 | 1442.65 | 27565.77 |
| Dr Lal Pathlabs | 2998.75 | 2.77 | 3398.95 | 1445.50 | 24991.58 |
| Pfizer | 5328.30 | 2.09 | 5875.00 | 3940.00 | 24376.97 |
| Glaxosmi. Pharma | 1424.50 | -3.07 | 1805.00 | 1258.00 | 24132.46 |
| Syngene Intl. | 596.55 | 1.22 | 644.65 | 273.80 | 23862.00 |
| Laurus Labs | 440.75 | -1.21 | 452.05 | 77.25 | 23650.64 |
Quick Links for Earum Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
